Drug profile

The FDA adverse-event record for Ivermectin 0.5% Pour-On

73 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Ivermectin 0.5% Pour-On. See the species affected, top reactions, and outcomes below.

73
adverse-event reports
1.4%
death-coded share
Cattle
most-reported species
19
Lack of efficacy (ectoparasite) - lice - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
73
Total Reports
1
Deaths Reported
1.4%
Death Rate

Active Ingredients

Ivermectin 0.5% Pour-On

Administration Routes

UnknownTopicalOtherOralTransdermalOphthalmic

Species Affected

Cattle 45
Human 14
Unknown 10
Dog 3
Pig 1

Most Affected Breeds

Unknown 24
Cattle (unknown) 17
Aberdeen Angus 15
Cattle (other) 6
Crossbred Bovine/Cattle 4
Dog (unknown) 2
Pig (unknown) 1
Hereford cattle 1
Holstein-Friesian also known as Holstein 1
Charolais 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - lice 19
Uncoded sign 14
Pruritus 10
Lack of efficacy - NOS 10
INEFFECTIVE, LICE BITING 8
Skin disorders NOS 8
Hair loss NOS 6
Containers, Damaged 5
Itching 5
General hair loss 5
Scratching 4
Nausea 4

Outcome Breakdown

Outcome Unknown
52 (82.5%)
Recovered/Normal
7 (11.1%)
Ongoing
2 (3.2%)
Died
1 (1.6%)
Recovered with Sequela
1 (1.6%)

Ivermectin 0.5% Pour-On Adverse Event Insights

73 reports name Ivermectin 0.5% Pour-On; 1 recorded a death outcome (1.4% of reported events, not a population-level mortality rate). Active ingredient: Ivermectin 0.5% Pour-On. Administration routes: Unknown, Topical, Other, Oral.

By species: Cattle (45 reports), Human (14 reports), Unknown (10 reports). By breed: Unknown (24), Cattle (unknown) (17), Aberdeen Angus (15).

Leading clinical signs: Lack of efficacy (ectoparasite) - lice (19), Uncoded sign (14), Pruritus (10), Lack of efficacy - NOS (10). Outcome, 63 coded reports: Outcome Unknown leads at 82.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.